Two strengths of berberine ursodeoxycholate improved HbA1c compared with placebo in a phase II trial. The higher-dose group also had improvements in other metabolic and liver markers. The treatment ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits … ...

Selpercatinib, a first-in-class, potent RET kinase inhibitor with central nervous system activity, shows sustained, significant improvements in progression-free survival (PFS) and overall survival (OS ...

PARIS — Consistent with what is known about minoxidil pharmacokinetics, a controlled trial found that an investigational extended-release oral formulation of minoxidil provided more favorable hair ...

Timing is everything for many things in life — including when to take medication like metformin, sold under the brand names ...

Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...

Metformin is a safe and effective oral medication for people with type 2 diabetes. Here's how it can help regulate blood-sugar levels.

The approval is the first in more than a decade for an idiopathic pulmonary fibrosis treatment. The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with ...

Pfizer Inc.’s stock tumbled 6% Friday, after the company said it would not move to a Phase 3 trial of a twice-daily formulation of a weight-loss drug after patients in an earlier study had a lot of ...

Beyond all the side effects outlined above, there's one specific concern that metformin users may encounter, which could ...

Jascayd is the first new IPF therapy approved in over 10 years, addressing a rare and serious disease with limited treatments. FDA approval was based on Phase III trials showing reduced FVC decline ...

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring and breathing difficulties. The approval marks the ...